Get startedLog in
    Picture of GENEMATRIX logo

    109820 — GENEMATRIX Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for GENEMATRIX, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsARSAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-722-8,111-895-3,748-1,834
    Depreciation
    Amortisation
    Non-Cash Items8598,871-3572,8782,246
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital2,752-2,309-1,67878332
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities3,369-1,023-2,346-2001,290
    Capital Expenditures-258-173-161-33.7-64.5
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-522-6,797-285-339-910
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-780-6,970-446-373-975
    Financing Cash Flow Items-78.4132214213120
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-12383.117216372.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash3,267-7,664-2,645-307407